ChenGuang Biotech Group Co., Ltd. (SHE:300138)
China
· Delayed Price · Currency is CNY 11.69
+0.32 (2.81%)
Apr 29, 2026, 3:04 PM CST
ChenGuang Biotech Group Revenue
ChenGuang Biotech Group had revenue of 1.63B CNY in the quarter ending March 31, 2026, a decrease of -5.10%. This brings the company's revenue in the last twelve months to 6.47B, down -7.26% year-over-year. In the year 2025, ChenGuang Biotech Group had annual revenue of 6.56B, down -6.22%.
Revenue (ttm)
6.47B
Revenue Growth
-7.26%
P/S Ratio
0.87
Revenue / Employee
3.11M
Employees
2,079
Market Cap
5.65B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 6.56B | -435.15M | -6.22% |
| Dec 31, 2024 | 6.99B | 122.68M | 1.79% |
| Dec 31, 2023 | 6.87B | 575.64M | 9.14% |
| Dec 31, 2022 | 6.30B | 1.42B | 29.18% |
| Dec 31, 2021 | 4.87B | 960.68M | 24.55% |
| Jan 1, 2021 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Jan 1, 2019 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Tech-Bank Food | 9.22B |
| Wellhope Foods | 36.61B |
| Shandong Xiantan Group | 5.62B |
| SDIC Fengle Seed | 2.90B |
| Jiangsu Chinagreen Biological Technology Group | 1.44B |
| Shanghai Xuerong Biotechnology | 1.85B |
| Guilin Layn Natural Ingredients | 2.04B |
| Tianshui Zhongxing Bio-technology | 2.23B |